Overview
Delve partners with ambitious teams to turn big ideas into market-ready products through product innovation studios in Boston, Madison, Philadelphia, and San Francisco, working with leading brands like GE HealthCare, Google, Johnson & Johnson, Kohler, P&G, and Stryker. It blends breakthrough creativity with rigorous de-risking and a focus on organizational alignment to define, envision, and develop innovations, using prototyping, experimentation, and cross-functional collaboration. Unlike others who only generate ideas, Delve combines fast creative work with structured risk reduction and multi-studio collaboration to deliver tangible business impact for complex clients. The goal is to help teams bring step-change innovations to market that produce real business results.
Work here?Claim your company
Simplify's take
What believers are saying
- July 2025 Series A raised $32 million at a $300 million valuation.
- Delve launched from stealth in 2025 with profitable operations and fast customer adoption.
- Fortune 500 CISOs joined the round, strengthening enterprise credibility and sales access.
What critics are saying
- TechCrunch reported April 2026 whistleblower claims of fake customer data and rubber-stamping auditors.
- April 2026 reports said Delve’s media inquiries address stopped working, signaling reputational breakdown.
- Compliance-trust failure destroys Delve if auditors, customers, or regulators reject its evidence integrity.
What makes Delve unique
- Insight Partners backed Delve’s AI agents automate compliance evidence collection in 2025.
- Delve serves hundreds of fast-growing companies, including 11x and Bland, from 2025 press.
- Delve’s MIT founder team targets regulatory busywork with agentic compliance workflows.
Help us improve and share your feedback! Did you find this helpful?